← Back to the Registry search

GreenLifeTech Corp

Point of Contact: Bruce Roesner
Title: CEO
Phone: 18583352343
Address: 197 Camelot Dr, Banner Elk, NC 28604-6309
NAICS Codes: 541715, 424480, 424410
Unique Entity Identifier (UEI): W5UWJ98CPEE4
CAGE Code: 90xr8
Business Set-Asides/Certifications: Small Business

Company Description

GreenLifeTechâ„¢ develops patented oxygen-removal technology that holds refrigerated red blood cells below 2% oxygen at normal atmospheric pressure, with no special bags, chemicals, or added labor. Oxidative damage during cold storage shortens blood shelf life and lowers transfusion quality, and the problem is worst in austere military and remote settings where resupply is slow. Our system retrofits existing blood refrigerators and coolers, extending usable blood supply where it matters most.

Critical Technology Areas

Technology areaSub-areaTRLMRL
Biomanufacturing (BIO) Bioengineering TRL 6 MRL 3
Industrial biotechnology TRL 6 MRL 3

Technology readiness level (TRL)

TRL 1
Basic scientific principles observed. Fundamental research begins.
TRL 2
Technology concept formulated. Practical applications identified.
TRL 3
Experimental proof of concept demonstrated through laboratory studies.
TRL 4
Components validated in a laboratory environment. Individual pieces work together.
TRL 5
Technology validated in a relevant environment that begins resembling operational conditions.
TRL 6
Prototype demonstrated in a relevant operational environment. Considered the beginning of serious transition activities.
TRL 7
System prototype demonstrated in an operational environment. Near field-ready.
TRL 8
Actual system completed, tested, and qualified for operational use.
TRL 9
Actual system proven through successful operational missions. Fully fielded capability.

Manufacturing readiness level (MRL)

MRL 1
Manufacturing implications identified. Basic manufacturing concepts considered.
MRL 2
Manufacturing concepts defined. Initial production approaches identified.
MRL 3
Manufacturing proof of concept demonstrated. Early processes evaluated.
MRL 4
Capability to produce NDAA compliant components in a laboratory environment.
MRL 5
Manufacturing processes demonstrated in a relevant environment.
MRL 6
Prototype manufacturing demonstrated. Processes becoming repeatable.
MRL 7
Manufacturing systems demonstrated in a production-representative environment.
MRL 8
Pilot production line established and capable of low-rate production.
MRL 9
Low-rate production proven. Quality, cost, and schedule are predictable.
MRL 10
Full-rate production demonstrated with lean, stable, repeatable manufacturing.